DENALI ADVISORS LLC

Position in AZN — Astrazeneca PLC

CIK 1142941 SAN DIEGO, CA

Position in AZN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,332,080

-$111,373 QoQ

Shares Held

7,025

-4.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#597

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 10% Shared 0% None 90%

Healthcare · as of Jun 30, 2026

DENALI ADVISORS LLC holds $21,250,231 across 5 Drug Manufacturers - General names. AZN ranks #4 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,917	$15,493,038
2	NVS	Novartis AG	13,287	$2,082,338
3	GSK	GSK plc	28,680	$1,503,405
4	AZN	Astrazeneca PLC This page	7,025	$1,332,080
5	JNJ	Johnson & Johnson	3,305	$839,370

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,332,080	7,025	-4.0%	Shares	Sole	2026-08-10
2026-03-31	$1,443,453	7,319	—	Shares	Sole	2026-05-08
No filing history on record for this holder in this stock.